Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.07

Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.07, versus $0.46 reported last year. Revenue for the quarter came in at $567 billion, versus $584 billion reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Standard Uranium extends private placement closing date to October 18
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)